EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Oxeiptosis in gastrointestinal cancer: molecular mechanisms, therapeutic strategies, and future perspectives

Islam Ahmed Abdelmawgood iD, Michael Ibrahim Boushra, Donia Mohamed Hussien, Esraa M Abdelhalim

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-12968-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 29.10.2026. Verfasst von Islam Ahmed Abdelmawgood und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt. ikasem@sci.cu.edu.eg. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Oxidative Stress, Apoptosis. Die Arbeit nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal (GI) malignancies represent a major global health burden characterized by high mortality rates, pronounced genomic heterogeneity, and resistance to conventional therapies. While cancer research has historically focused on apoptosis, non-canonical regulated cell death (RCD) pathways have recently emerged as critical regulators of oncogenesis and tumor suppression. Among these pathways, oxeiptosis is a recently identified, non-inflammatory, and caspase-independent cell death mechanism triggered by hyperphysiological levels of reactive oxygen species (ROS). This pathway is mechanistically governed by the mitochondrial Kelch-like ECH-associated protein 1 (Keap1)/phosphoglycerate mutase family member 5 (PGAM5)/ apoptosis-inducing factor mitochondria-associated 1 (AIFM1) signaling axis. Under conditions of toxic oxidative stress, elevated ROS levels activate Keap1, facilitating the PGAM5-mediated dephosphorylation of AIFM1. This review synthesizes the pathophysiological roles of oxidative stress and the regulatory landscape of oxeiptosis across major GI cancers, including esophageal, gastric, colorectal (CRC), pancreatic, and hepatocellular carcinomas (HCC) 1. Although clinical translation in esophageal and pancreatic cancers is currently constrained by a paucity of direct experimental data, recent multi-omics and bioinformatics analyses have identified oxeiptosis-related gene signatures as robust prognostic and therapeutic biomarkers in gastric cancer and HCC. Furthermore, preclinical evidence demonstrates that small molecules and natural products can successfully exploit the oxeiptotic cascade to bypass established apoptotic resistance. Specifically, the natural compounds sanguinarine and auriculasin trigger potent, PGAM5-dependent oxeiptosis in CRC models, while phenethyl isothiocyanate, dasatinib, and methyl-cantharidimide exhibit strong therapeutic synergy in HCC cell lines. Collectively, targeting oxeiptosis represents a highly promising preclinical strategy to overcome chemoresistance in GI malignancies; however, further in vitro, in vivo, and clinical investigations are essential to validate its therapeutic efficacy and determine whether modulating this pathway translates into improved patient survival and clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal NeoplasmsOxidative StressApoptosisHumansReactive Oxygen SpeciesSignal TransductionKelch-Like ECH-Associated Protein 1AnimalsApoptosis Inducing FactorPhosphoprotein PhosphatasesIsoquinolinesMitochondrial ProteinsBenzophenanthridines

Stichwörter der Autor:innen

Gastrointestinal cancerKeap1/PGAM5/AIFM1OxeiptosisProgrammed cell death

Substanzen

Reactive Oxygen SpeciesKelch-Like ECH-Associated Protein 1PGAM5 protein, humanApoptosis Inducing FactorPhosphoprotein PhosphatasesKEAP1 protein, humansanguinarineIsoquinolinesMitochondrial ProteinsBenzophenanthridines

Autor:innen und Institutionen

  • Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt. ikasem@sci.cu.edu.eg.
  • Biotechnology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt.

ORCID-Profile: Islam Ahmed Abdelmawgood

Zitieren

APA

Abdelmawgood, I. A., Boushra, M. I., Hussien, D. M., & Abdelhalim, E. M. (2026). Oxeiptosis in gastrointestinal cancer: molecular mechanisms, therapeutic strategies, and future perspectives. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12968-4

Vancouver

Abdelmawgood IA, Boushra MI, Hussien DM, Abdelhalim EM. Oxeiptosis in gastrointestinal cancer: molecular mechanisms, therapeutic strategies, and future perspectives. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12968-4

BibTeX
@article{Abdelmawgood2026,
  author = {Abdelmawgood, Islam Ahmed and Boushra, Michael Ibrahim and Hussien, Donia Mohamed and Abdelhalim, Esraa M},
  title = {Oxeiptosis in gastrointestinal cancer: molecular mechanisms, therapeutic strategies, and future perspectives},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-12968-4}
}
Kostenlos starten →